TOPLINE: Depression is linked to a significantly increased risk for cardiovascular disease (CVD), particularly in women, new data from a large retrospective cohort study show. Researchers […]

Adverse childhood experiences (ACEs) are associated with a significantly increased risk for adult depressive, anxiety, and stress-related disorders, new data from a large registry study of […]

TOPLINE: Mental health-related outpatient visits and use of psychotropic medications among adolescents and young adults increased significantly between 2006 and 2019, before the COVID-19 pandemic, a […]

TOPLINE: Schizophrenia is associated with a significantly higher risk of developing cardiovascular disease (CVD), with a more pronounced relationship in women, results of a new study […]

Initiating drug treatment forattention-deficit/hyperactivity disorder (ADHD) is associated with significantly lower all-cause mortality, particularly for deaths caused by accidental poisoning, suicide, or accidental injury, new data […]

Nearly 18 months after the US Food and Drug Administration (FDA) first acknowledged a national shortage of Adderall, the most common drug used to treat attention-deficit/hyperactivity […]

(Reuters) -Acadia Pharmaceuticals said on Monday it does not plan to conduct further clinical trials of its antipsychotic drug, pimavanserin, after it failed to improve negative […]

The US Food and Drug Administration (FDA) has granted breakthrough designation to an LSD-based treatment for generalized anxiety disorder (GAD) based on promising topline data from […]

A large global report has found ongoing poor mental well-being worldwide, with no sign of improvement since prior to the COVID-19 pandemic. Published online on March […]